Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.5401
-0.0064 (-1.17%)
Oct 7, 2026, 12:16 PM EDT - Market open
Tenaya Therapeutics Market Cap
Tenaya Therapeutics has a market cap or net worth of $121.11 million as of October 7, 2026. Its market cap has decreased by -56.80% in one year.
Market Cap
121.11M
Enterprise Value
46.97M
1-Year Change
-56.80%
Ranking
Category
Stock Price
$0.54
ChartMarket Cap Chart
Since July 30, 2021, Tenaya Therapeutics's market cap has decreased from $603.63M to $121.11M, a decrease of -79.94%. That is a compound annual growth rate of -26.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 121.11M | -21.38% |
| Dec 31, 2025 | 154.04M | 35.98% |
| Dec 31, 2024 | 113.29M | -48.67% |
| Dec 29, 2023 | 220.68M | 71.58% |
| Dec 30, 2022 | 128.62M | -83.56% |
| Dec 31, 2021 | 782.28M | 29.59% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PMV Pharmaceuticals | 129.88M |
| Cibus | 128.40M |
| Spruce Biosciences | 126.57M |
| Caribou Biosciences | 126.50M |
| Kazia Therapeutics | 125.80M |
| Seer, Inc. | 124.86M |
| NRx Pharmaceuticals | 122.00M |
| enGene Therapeutics | 121.30M |